Atrial Fibrillation Trial, Recruiting NCT05367037 Sponsor: Quovadis Associazione Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT05367037
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older and able to give your own consent to participate
  • You have a longer-than-normal delay in the electrical signal between the upper and lower chambers of your heart (a measurement called PR interval greater than 180 ms on a heart tracing)
  • You have been recommended to receive a pacemaker because of a problem with your heart's natural pacemaker (sinus node disease) OR because of a certain type of irregular heartbeat where the signal between heart chambers occasionally fails to get through (paroxysmal second-degree AV block, type 1 or 2)

Who may not be able to join:

  • You are being considered for a device that corrects dangerous heart rhythms (implantable defibrillator) or a device that helps both sides of the heart beat together (cardiac resynchronization therapy)
  • You have a severe problem with one of your heart valves (the mitral or aortic valve), either leaking badly or significantly narrowed
  • You have previously had a procedure to treat an irregular heartbeat involving the left side of your heart's upper chamber (atrial fibrillation ablation targeting the left pulmonary veins)
  • You have had heart surgery less than 3 months before the planned pacemaker implantation
  • You have a long history of a continuous irregular heart rhythm called persistent atrial fibrillation
  • You have a permanent, complete blockage of the electrical signal between the upper and lower chambers of your heart (permanent third-degree AV block)
  • You have taken part in another clinical trial within the past 3 months
  • You are pregnant or planning to become pregnant
  • Your doctors estimate your life expectancy is less than 3 years

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Gianni Pastore, MD, Cardiology Unit, "S.Maria della Misericordia" Hospital, Rovigo, Italy

Phone: ‭+39 (339) 754-4514‬

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Quovadis Associazione
Registry
ClinicalTrials.gov
Start date
27 July 2022
Est. completion
1 December 2028

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

PeAF Free; Clinical composite outcome

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov